058820.KQ
CMG Pharmaceutical Co., Ltd. [058820.KQ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
058820.KQ Stock Summary
Top 10 Correlated ETFs
058820.KQ
Top 10 Correlated Stocks
058820.KQ
In the News
058820.KQ Financial details
Company Rating
-
Market Cap
300.01B
Income
6.46B
Revenue
93.91B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
265
Optionable
No
Shortable
Yes
Earnings
18 Mar 2021
P/E
0.04
Forward P/E
-
PEG
-0
P/S
0.03
P/B
0.02
P/C
-
P/FCF
0.18
Quick Ratio
1.4
Current Ratio
1.53
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
65
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
75.84%
Revenue Q/Q
-6.61%
EPS Q/Q
-
-
-
-
-
SMA20
-2.47%
SMA50
-6.1%
SMA100
-16.88%
Inst Own
-
Inst Trans
-
ROA
15%
ROE
45%
ROC
0.22%
Gross Margin
41%
Oper. Margin
16%
Profit Margin
12%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1993.0-2830.0
52W High
-36.57%
52W Low
-9.93%
RSI
44
Rel Volume
4.59
Avg Volume
368.14K
Volume
1.69M
Perf Week
1.3%
Perf Month
-6.32%
Perf Quarter
-22.13%
Perf Half Y
-23.29%
-
-
-
-
Beta
0.743
-
-
Volatility
36.66%, 39.78%
Prev Close
-0.39%
Price
1795
Change
-0.55%
Company Profile
- Volume Average 368.14K
- Market Capitalization 300.01B
- Employee 265
- CEO Joohyung Lee
- Headquarters Seoul,KR
- IPO Date 2001-11-19
-
Website
https://www.cmgpharma.co.kr 
CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutical CO., Ltd. in April 2013. CMG Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Seoul, South Korea.
